Conclusion
As the popularity of COVID-19 continues to spread globally, we need to
plan and prepare well. Obstetricians and gynaecologists will be at the
forefront of special patient management, so we need to know more about
the virology, epidemiology and clinical data of COVID-19. Learn from the
past experience of SARS, understand the current epidemiological factors
of COVID-19, master the knowledge of infection prevention and control,
and do well in the treatment of infected patients on the premise of
self-protection. Using a multidisciplinary team management approach,
sharing data, knowledge and expertise are very important.
Author contributions Hongyuan Zhang and Wei Chen: Preparation,
manuscript original writing. Yuanjing Hu: Supervision and manuscript
review. Yingjun Zhu and Xu Chen: Edit and data collection.
Acknowledgements The authors are grateful to the staff of the
Oncology, Obstetrics and emergency department at the Tianjin Central
Gynecology and Obstetrics Hospital for their kind assistance and
collaboration in data collection.
Disclosure of Interests The authors report no conflict of
interests.
Details of ethics approval No ethics approval applicable for
this commentary
Funding This work was supported by the Tian Jin Science
Foundation of China under Grant 17JCYBJC26900.
REFERENCES
[1] Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H,
et al. First case of 2019 novel coronavirus in the United States. N Engl
J Med. 2020;382(10): 929-936.
[2] Wu F, Zhao S, Yu B, Chen YM, Wang W, Song AG, et al. A new
coronavirus associated with human respiratory disease in China. Nature.
2020;579(7798):265-269.
[3] WHO. Report of the WHO-China Joint Mission on Coronavirus
Disease 2019 (COVID-19). February, 2020.
[4] Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al.
SARS-CoV-2 viral load in upper respiratory specimens of infected
patients. New Engl J Med 2020;382(12):1177-1179.
[5] Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical
characteristics and intrauterine vertical transmission potential of
COVID‐19 infection in nine pregnant women: a retrospective review of
medical records. The Lancet. 2020;395(10226): 809-815.
[6] Gagneur A, Dirson E, Audebert S, Vallet S, Quillien M, Baron R,
et al. Vertical transmission of human coronavirus. Prospective pilot
study. Pathol Biol (Paris). 2007;55(10):525-530.
[7] Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of
chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in
China: a report of 1014 cases. Radiology. 2020; Feb 26:200642..
[8] Mair‐Jenkins J, Saavedra‐Campos M, Baillie JK, Cleary P, Khaw
FM, Lim WS, et al. The effectiveness of convalescent plasma and
hyperimmune immunoglobulin for the treatment of severe acute respiratory
infections of viral etiology: a systematic review and exploratory
meta‐analysis. J Infect Dis. 2015;211(1):80‐90.
[9] Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir
and chloroquine effectively inhibit the recently emerged novel
coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-271.
[10] Weinberger S, Weiss S, Cohen W, Weiss J, Johnson T. Pregnancy
and The Lung. American Review of Respiratory Disease.
1980;121(3):559-581.